GLP-1

Dick lost 167 pounds over 18 months — a 45% transformation that proves it's never too late to reclaim your life.

Obesity-related heart disease deaths are rising fast, but breakthroughs in research and care are offering new hope.

Patients who discuss weight directly with their doctor are 32% more likely to lose meaningful weight within a year.

Chesapeake Cardiac Care and Enara join forces to bring heart-focused weight management to patients across Maryland.

US obesity rates dropped from 41.9% to 40.3% — a promising sign that new medications and strategies are making an impact.

Compounded GLP-1 medications are becoming common during shortages, but not all sources are safe — here's what to know.

With obesity rates over 35% in 23 states, new research breakthroughs offer real hope for turning the tide.

As a young mom balancing work and two kids, Jasmine proved that sustainable health transformation fits into a busy life.

Retired Air Force veteran Christopher Huard found lasting change through Enara's Phoenix Heart partnership in Arizona.

Enara Health partners with Jiomed Family Care in Kansas to bring evidence-based, personalized obesity care to more patients.

From tirzepatide's diabetes prevention power to personalized care models, new discoveries are transforming obesity treatment.

The future of obesity care goes beyond the scale — considering body composition, psychology, and individual medical needs.